High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab

被引：0
|
作者：
Becker, W [1 ]
Behr, T [1 ]
机构：
[1] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
来源：
ANNALS OF HEMATOLOGY | 2001年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B130 / B131
页数：2
相关论文
共 50 条
  • [1] High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 Rituximab
    W. Becker
    Th. Behr
    Annals of Hematology, 2001, 80 (Suppl 3) : B130 - B131
  • [2] REPEATED RADIOIMMUNOTHERAPY (RIT) WITH I-131 RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS
    Kang, H. J.
    Lim, S. M.
    Cheon, G. J.
    Choi, C. W.
    Lee, S. S.
    Na, I. I.
    Ryoo, B. Y.
    Kim, W. S.
    Nam, S. H.
    Park, Y. H.
    Suh, C.
    Eom, H. S.
    Yang, S. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 100 - 100
  • [3] REPEATED RADIOIMMUNOTHERAPY (RIT) WITH I-131 RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS
    Kang, H. J.
    Lim, S. M.
    Cheon, G. J.
    Choi, C. W.
    Lee, S. S.
    Kim, W. S.
    Park, Y. H.
    Ryoo, B.
    Na, I. I.
    Yang, S. H.
    ANNALS OF ONCOLOGY, 2008, 19 : 232 - 232
  • [4] High-dose radioimmunotherapy in refractory B-cell non-Hodgikin lymphoma with I-131-labeled chimeric anti CD-20 (I-131 rituximab): pilot trial
    Cheon, G.
    Kim, S.
    Park, Y.
    Choi, C.
    Lim, S.
    Lee, S.
    Ryu, B.
    Yang, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S205 - S205
  • [5] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [6] Radioimmunotherapy in relapsed or refractory B-cell non-hodgkin's lymphoma with I-131-labeled chimericanti CD20 C2B8 (I-131 rituximab)
    Kang, H. J.
    Park, Y. H.
    Kim, S.
    Cheon, G. J.
    Choi, C. W.
    Lim, S. M.
    Lee, S. S.
    Na, I. I.
    Ryoo, B. Y.
    Yang, S. H.
    Kim, W. S.
    Kim, K. H.
    Bang, S. M.
    Yuh, Y. J.
    Nam, S. H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 109
  • [7] RADIOIMMUNOTHERAPY OF PATIENTS WITH B-CELL LYMPHOMA USING I-131 LYM-1 MAB
    DENARDO, SJ
    DENARDO, GL
    OGRADY, LF
    MACEY, DJ
    MILLS, SL
    PENG, JS
    STEWART, SL
    EPSTEIN, AL
    MCGAHAN, JP
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 903 - 903
  • [8] Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
    Shin, Dong-Yeop
    Byun, Byung Hyun
    Kim, Kyeong Min
    Kang, Joo Hyun
    Lim, Ilhan
    Kim, Byung Il
    Lee, Seung-Sook
    Choi, Chang Woon
    Kang, Hye Jin
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 825 - 831
  • [9] Radioimmunotherapy with 131I-rituximab as consolidation therapy for patients with diffuse large B-cell lymphoma
    Dong-Yeop Shin
    Byung Hyun Byun
    Kyeong Min Kim
    Joo Hyun Kang
    Ilhan Lim
    Byung Il Kim
    Seung-Sook Lee
    Chang Woon Choi
    Hye Jin Kang
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 825 - 831
  • [10] Intratumoral microdistribution of [I-131]MB-1 in patients with B-cell lymphoma following radioimmunotherapy
    Brown, RS
    Kaminski, MS
    Fisher, SJ
    Chang, AE
    Wahl, RL
    NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (07): : 657 - 663
12345